Autoimmune conditions

RESEARCH

 

 

 

 

HASHIMOTO and Mercury exposure: RESEARCH

Mercury and thyroid autoantibodies in U.S. women, NHANES 2007-2008

Carolyn M Gallagher 1 , Jaymie R Meliker 2

Abstract

Associations between positive thyroid autoantibodies and total blood mercury in women were evaluated using the National Health and Nutrition Examination Survey (NHANES), 2007-2008. Women are at increased risk for autoimmune disorders, mercury exposure has been associated with cellular autoimmunity and mercury accumulates in the thyroid gland. We used multiple logistic regression to evaluate the associations between total bloodmercury and thyroglobulin autoantibody antibody positivity and thyroid peroxidase autoantibody positivity in non-pregnant, non-lactating women aged 20 and older not currently using birth control pills or other hormone therapies, adjusted for demographic factors, menopausal status, nutrient intake and urine iodine (n=2047). Relative to women with the lowest mercury levels (≤0.40 μg/L), women with mercury >1.81 μg/L (upper quintile) showed 2.24 (95% CI=1.22, 4.12) greater odds for thyroglobulin autoantibody positivity (p(trend)=0.032); this relationship was not evident for thyroid peroxidase autoantibody positivity. Results suggest an association between mercury and thyroglobulin autoantibody positivity.

 

Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism

Roger Pamphlett  1   2 , Philip A Doble  3 , David P Bishop  3
Affiliations

Free PMC article

Abstract

Objective: Mercury and other toxic metals have been suggested to be involved in thyroid disorders, but the distribution and prevalence of mercury in the human thyroid gland is not known. We therefore used two elemental bio-imaging techniques to look at the distribution of mercury and other toxic metals in the thyroid glands of people over a wide range of ages.

Materials and methods: Formalin-fixed paraffin-embedded thyroid tissue blocks were obtained from 115 people aged 1-104 years old, with varied clinicopathological conditions, who had thyroid samples removed during forensic/coronial autopsies. Seven-micron sections from these tissue blocks were used to detect intracellular inorganic mercury using autometallography. The presence of mercury was confirmed using laser ablation-inductively coupled plasma-mass spectrometry which can detect multiple elements.

Results: Mercury was found on autometallography in the thyroid follicular cells of 4% of people aged 1-29 years, 9% aged 30-59 years, and 38% aged 60-104 years. Laser ablation-inductively coupled plasma-mass spectrometry confirmed the presence of mercury in samples staining with autometallography, and detected cadmium, lead, iron, nickel and silver in selected samples.

Conclusions: The proportion of people with mercury in their thyroid follicular cells increases with age, until it is present in over one-third of people aged 60 years and over. Other toxic metals in thyroid cells could enhance mercury toxicity. Mercury can trigger genotoxicity, autoimmune reactions, and oxidative damage, which raises the possibility that mercury could play a role in the pathogenesis of thyroid cancers, autoimmune thyroiditis, and hypothyroidism.

 

 

BOTANICALS, GUT HEALTH, ULCERATIVE COLITIS

2023 Jul 3:14:1215329.

doi: 10.3389/fimmu.2023.1215329. eCollection 2023.

Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study

Antonietta Gerarda Gravina  1 , Raffaele Pellegrino  1 , Giovanna Palladino  1 , Annachiara Coppola  1 , Giovanni Brandimarte  2 , Concetta Tuccillo  3 , Fortunato Ciardiello  3 , Marco Romano  1 , Alessandro Federico  1
Affiliations

Free PMC article

Abstract

Hericium erinaceus, berberine, and quercetin are effective in experimental colitis. It is unknown whether they can ameliorate inflammatory bowel diseases in humans. This ex vivo study aimed to evaluate the anti-inflammatory potential of a nutraceutical compound of HBQ-Complex® (H. erinaceus, berberine, and quercetin), biotin, and niacin in inflammatory bowel disease patients. Tissue specimens were obtained either from Normal-Appearing Mucosa (NAM) or from Inflamed Mucosa (IM) in 20 patients with inflammatory bowel disease. mRNA and protein expression of COX-2, IL-10, and TNF-α were determined in NAM and IM biopsy samples (T0). IM samples were then incubated in HBQ-Complex® (with the addition of niacin and biotin), and COX-2, IL-10, and TNF-α tissue levels were evaluated at 120 minutes (T1) and 180 minutes (T2). Incubation with this compound resulted in a progressive decrease in gene and protein COX-2 and TNF-α expression at T1/T2 in the IM. IL-10 showed an opposite trend, with a progressive increase of mRNA and protein expression over the same time window. HBQ-Complex® (with the addition of niacin and biotin) decreased the expression of proinflammatory cytokines at the mRNA and protein levels in IBD tissue. On the contrary, mRNA and protein expression of the anti-inflammatory cytokine IL-10 showed a progressive increase.

 2017 Aug 2;7(1):7139.

 

 

 

 

 

doi: 10.1038/s41598-017-07280-y.

Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis

Hesham Aly Salem  1 , Walaa Wadie  2

Free PMC article

Abstract

Butyrate and niacin are produced by gut microbiota, however butyrate has received most attention for its effects on colonic health. The present study aimed at exploring the effect of niacin on experimental colitis as well as throwing some light on the ability of niacin to modulate angiogenesis which plays a crucial role of in the pathogenesis of inflammatory bowel disease. Rats were given niacin for 2 weeks. On day 8, colitis was induced by intrarectal administration of iodoacetamide. Rats were sacrificed on day 15 and colonic damage was assessed macroscopically and histologically. Colonic myeloperoxidase (MPO), tumour necrosis factor (TNF)-α, interleukin (IL)-10, vascular endothelial growth factor (VEGF), angiostatin and endostatin levels were determined. Niacin attenuated the severity of colitis as demonstrated by a decrease in weight loss, colonic wet weight and MPO activity. Iodoacetamide-induced rise in the colonic levels of TNF-α, VEGF, angiostatin and endostatin was reversed by niacin. Moreover, niacin normalized IL-10 level in colon. Mepenzolate bromide, a GPR109A receptor blocker, abolished the beneficial effects of niacin on body weight, colon wet weight as well as colonic levels of MPO and VEGF. Therefore, niacin was effective against iodoacetamide-induced colitis through ameliorating pathologic angiogenesis and inflammatory changes in a GPR109A-dependent manner.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

References:

Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., & Tenborg, M. (2006). Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Alternative medicine review : a journal of clinical therapeutic, 11(2), 128–150

Safari, H., Anani Sarab, G., & Naseri, M. (2019). Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model. Nutritional neuroscience, 1–7. Advance online publication. https://doi.org/10.1080/1028415X.2019.1681742

Lai, C. Y., Su, Y. W., Lin, K. I., Hsu, L. C., & Chuang, T. H. (2017). Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation. Journal of immunology research, 2017, 7807313. https://doi.org/10.1155/2017/7807313

Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013). Curcumin, a component of turmeric: from farm to pharmacy. BioFactors (Oxford, England), 39(1), 2–13. https://doi.org/10.1002/biof.1079

Jafarzadeh, A., & Nemati, M. (2018). Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties. Journal of neuroimmunology, 324, 54–75. https://doi.org/10.1016/j.jneuroim.2018.09.003

Ammon H. P. (2010). Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine : international journal of phytotherapy and phytopharmacology, 17(11), 862–867. https://doi.org/10.1016/j.phymed.2010.03.003

Rito, Y., Torre-Villalvazo, I., Flores, J., Rivas, V., & Corona, T. (2018). Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention. Central nervous system agents in medicinal chemistry, 18(1), 8–15. https://doi.org/10.2174/1871524916666160226131842

Chalons, P., Amor, S., Courtaut, F., Cantos-Villar, E., Richard, T., Auger, C., Chabert, P., Schni-Kerth, V., Aires, V., & Delmas, D. (2018). Study of Potential Anti-Inflammatory Effects of Red Wine Extract and Resveratrol through a Modulation of Interleukin-1-Beta in Macrophages. Nutrients, 10(12), 1856. https://doi.org/10.3390/nu10121856

Cui, C., Wang, J. J., Zhao, J. H., Fang, Y. Y., He, X. F., Guo, H. S., & Duan, C. G. (2020). A Brassica miRNA Regulates Plant Growth and Immunity through Distinct Modes of Action. Molecular plant, 13(2), 231–245. https://doi.org/10.1016/j.molp.2019.11.010

Javadi, B., & Sahebkar, A. (2017). Natural products with anti-inflammatory and immunomodulatory activities against autoimmune myocarditis. Pharmacological research, 124, 34–42. https://doi.org/10.1016/j.phrs.2017.07.022

Cavalieri, D., Rizzetto, L., Tocci, N., Rivero, D., Asquini, E., Si-Ammour, A., Bonechi, E., Ballerini, C., & Viola, R. (2016). Plant microRNAs as novel immunomodulatory agents. Scientific reports, 6, 25761. https://doi.org/10.1038/srep25761

Shishodia S. (2013). Molecular mechanisms of curcumin action: gene expression. BioFactors (Oxford, England), 39(1), 37–55. https://doi.org/10.1002/biof.1041

Yamamoto, E. A., & Jørgensen, T. N. (2020). Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Frontiers in immunology, 10, 3141. https://doi.org/10.3389/fimmu.2019.03141

 

 

 

 

Open Hours

By appointment only.

Foreign Languages Welcome:

Spanish, German, Italian, French, Portuguese

USA location: 17505 N 79th Ave, Glendale AZ 85308, Suite 213

 

Fax: 602-926-2773

Email Us

Contact: magnoliapersonalizedmedicine@gmail.com

Findatopdoc Top Doctor Badge
Dr. Ellie Wright

Privacy Policy

Medicinary

We accept all major credit/debit cards, cash, checks